CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-01 | Mokari Atabak Chief Financial Officer | Grant or award | +178 | 14,677 | ||
| 2025-12-01 | Robb Gary Charles Chief Business Officer | Grant or award | +224 | $79.78 | $18K | 13,834 |
| 2025-12-01 | Robb Gary Charles Chief Business Officer | Grant or award | +224 | 14,058 | ||
| 2025-12-01 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −40,000 | $79.77 | $3.2M | 2,701,370 |
| 2025-11-25 | Guyer William Chief Development Officer | Sale | −4,500 | $80.90 | $364K | 787 |
| 2025-11-25 | Guyer William Chief Development Officer | Sale | −4,500 | $80.90 | $364K | 787 |
| 2025-11-17 | Guyer William Chief Development Officer | Gift | −5,287 | 0 | ||
| 2025-11-17 | Guyer William Chief Development Officer | Other acquisition | +5,287 | 5,287 | ||
| 2025-11-05 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +20,000 | $21.65 | $433K | 25,287 |
| 2025-11-05 | Guyer William Chief Development Officer | Sale 10b5-1 | −6,536 | $74.75 | $489K | 18,751 |
| 2025-11-05 | Guyer William Chief Development Officer | Sale 10b5-1 | −13,164 | $75.64 | $996K | 5,587 |
| 2025-11-05 | Guyer William Chief Development Officer | Sale 10b5-1 | −300 | $76.28 | $23K | 5,287 |
| 2025-11-05 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 290,000 | ||
| 2025-11-05 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −14,355 | $74.20 | $1.1M | 2,755,797 |
| 2025-11-05 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −10,837 | $75.14 | $814K | 2,744,960 |
| 2025-11-05 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −3,590 | $75.98 | $273K | 2,741,370 |
| 2025-11-03 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +5,000 | $13.56 | $68K | 15,277 |
| 2025-11-03 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −5,000 | $73.65 | $368K | 10,277 |
| 2025-11-03 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −5,000 | 16,571 | ||
| 2025-11-03 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −11,218 | $74.08 | $831K | 2,770,152 |
Page 17 of 61 · 1,220 trades